ISTH 2020 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB2436

Saddle Pulmonary Embolism in the Era of Incidental Events: Incidence, Clinical Findings and Outcomes in a Single Center Cohort

M. Aramberri¹, M. Sanchez², M. Benegas², E. Segui², A. García-Villa², M. Carnevali¹, C. Font², C. Diaz-Pedroche¹, 4S project
Abstract Number: PB2318

Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes

K. Wong, M. Kushnir, H. Billett
Abstract Number: PB0923

Safety and Efficacy of Albutrepenonacog Alfa ih Haemophilia Patients: The Greek Experience

M. Economou¹, A. Adramerina¹, E. Pergantou², E. Nomikou³, O. Katsarou⁴
Abstract Number: OC 12.2

Safety and Efficacy of Anticoagulant Therapy in Pediatric Catheter-related Venous Thrombosis (EINSTEIN-Jr. CVC-VTE): A Pre-specified Substudy

K. Thom¹, A.W.A. Lensing², D. Kubitza², A.F. Pap², M.H. Prins³, G. Kenet⁴, M.P. Massicotte⁵, A.K. Chan⁶, P. Monagle⁷, G. Young⁸, C. Male¹, EINSTEIN Jr CVC-VTE Investigators
Abstract Number: PB0960

Safety and Efficacy of FVIII Replacement with Turoctocog Alfa in the UK

B. Palmer¹, H. Xiang¹, P. Collins², G. Dolan³, J. Hanley⁴, S. Shapiro⁵, C. Hay¹
Abstract Number: PB1211

Safety of Antithrombotic Therapy in Subjects with Hereditary Hemorrhagic Telangiectasia

E. Gaetani, F. Agostini, A. Porfidia, I. Giarretta, D. Feliciani, L. Di Martino, A. Tortora, A. Gasbarrini, R. Pola
Abstract Number: PB2281

Safety of Using the Wells Rule and D-Dimer Test for Excluding Acute Recurrent Ipsilateral Deep Vein Thrombosis

L.F. van Dam¹, G. Gautam², C.E.A. Dronkers^1,3, Å. Eckerbom², W. Ghanima^4,5, J. Gleditsch⁶, A. von Heijne², H.M.A. Hofstee³, M.M.C. Hovens⁷, M.V. Huisman¹, S. Kolman⁸, A.T.A. Mairuhu⁹, M. Nijkeuter¹⁰, M.A. van de Ree⁸, C.J. van Rooden¹¹, R.E. Westerbeek¹², J. Westerink¹⁰, E. Westerlund², L.J.M. Kroft¹³, F.A. Klok¹
Abstract Number: PB2514

Safety of Withholding Antithrombotic Treatment in Pregnancies after Antiphospholipid Antibodies Disappearance in Women with Obstetric Antiphospholipid Syndrome, a Cohort Study

M.M. Clavijo, C. Casali, C. Mahuad, M.D.l.A. Vicente Reparaz, M.F. Aizpurua, A. Delorenzi, A. Ventura, S. Eciolaza, M. Zerga, G. Garate
Abstract Number: PB0545

Sample Stability for a Broad Panel of Coagulation Assays on the Cobas t 711 Analyser Using Plasma Stored under Different Conditions

M. Hoffmann¹, N. Gottschalk¹, P. Huber², N. von Allmen-Zürcher³
Abstract Number: PB1834

Sarcoidosis and Autoimmune Thrombocytopenic Purpura: Random Association or Hematologic Manifestation of Sarcoidosis?

Y. Cherif, M. Mrouki, S. Derbel, F. Ben Dahmen, M. Abdallah
Abstract Number: PB1057

Satisfaction and Preference of Hemophilia A Patients and Parents for the Treatments in Korea; Results from a Multicentered, Cross-sectional, Observational Study

K.Y. Yoo¹, T.J. Hwang¹, Y.S. Park², Y.J. Kim³, H.R. Park³, J.S. Shin⁴, H.J. Lee⁴, C.M. Nam⁵, J.Y. Sun⁵
Abstract Number: PB0334

Screening of Hematuria in Children with Hemophilia: A Preliminary Report

D. Gurlek Gokcebay, V. Culha, V. Kose, N. Yarali, N.Y. Ozbek
Abstract Number: PB0924

Screening of Inhibitor Development among Haemophilia a Patients Being Treated with Recombinant Factor VIII Concentrates in South-East Nigeria

E. Ezigbo¹, C. Nwankwo¹, T. Nwagha²
Abstract Number: PB2337

Seasonality in Hospitalizations for Pulmonary Embolism between 2006 – 2016

A. Torres¹, K. Quelal¹, A. Tafur², C. Torres³
Abstract Number: PB0958

Second Interim Analysis Results from the STASEY Trial: A Single-Arm, Multicenter, Open-Label, Phase III Clinical Trial to Evaluate the Safety and Tolerability of Emicizumab Prophylaxis in People with Hemophilia A (PwHA) with FVIII Inhibitors

V. Jiménez-Yuste¹, E. Santagostino², R. Klamroth³, G. Castaman⁴, C. Shanmukhaiah⁵, S. Rangarajan⁶, J. García Chavez⁷, R. Martinez⁸, G. Kenet⁹, S. Robson¹⁰, C. Schmitt¹⁰, O. Meier¹⁰, M. Ozelo¹¹
Abstract Number: PB0099

Secondary Brain Damage in Mouse Models of Focal and Global Ischaemia and Haemorrhagic Stroke: A Comparative Study

N. Lee¹, C. Selan¹, J. Chia¹, S. Sturgeon¹, D. Wright², A. Zamani², M. Pereira¹, H. Nandurkar^1,3, M. Sashindranath¹
Abstract Number: PB1241

Secondary Immune Thrombocytopenia in Children: Characteristics and Outcome of a Large Cohort from Two Spanish Centers

R. Berrueco Moreno^1,2,3, E. Sebastian⁴, M. Solsona^1,2, J. González de Pablo^3,4, A. Ruiz-Llobet^1,2, J. Sevilla^3,4,5
Abstract Number: PB1915

Secondary Thromboprophylaxis in Antiphospholipid Syndrome Patients with Arterial Thrombosis: A Systematic Review and Meta-analysis

T. Attachaipanich¹, A. Aungsusiripong², P. Piriyakhuntorn¹, S. Huntrakul¹, E. Rattarittamrong¹, T. Rattanathammethee¹, A. Tantiworawit¹, L. Norrasethada¹, C. Chai-Adisaksopha¹
Abstract Number: PB0810

Seeking New Approaches: Aberrant Clots, Fibrin Degradation Products and their Effects on Clot Stability

C. Rea, R. Arya
Abstract Number: PB1465

Selatogrel, a Potent P2Y12 Receptor Antagonist, Dissolves Pre-Formed Platelet-thrombi in vivo

L. Crescence¹, M. Kramberg², M. Baumann³, M. Rey², L. Panicot-Dubois¹, C. Dubois¹, M.A. Riederer³
Abstract Number: PB0032

Selective Targeting of Shear Gradient Activated Von Willebrand Factor by the Novel Single-Chain Antibody Scfv-A1 Reduces Occlusive Thrombus Formation

A. Rana¹, T. Hoefer², B. Niego¹, S. Jagdale^1,2, H.J. Albers³, E.E. Gardiner⁴, R.K. Andrews¹, A.D. van der Meer³, C.E. Hagemeyer^1,2, E. Westein^1,2
Abstract Number: PB0809

Self-Adjustment of Prescribed Dosing Regimens and Physical Activity by Persons with Hemophilia (PwH): Findings from the HemACTIVE Patient Survey

D. Nugent¹, A. Llinas², K. Khair³, J. O'Hara^4,5
Abstract Number: PB1268

Self-Management of Oral Anticoagulation with Vitamin K Antagonist Programs Progressively Improves Time in Therapeutic Range in Pediatric Population

R. Berrueco^1,2, C. Benedicto^1,2, A. Ruiz-Llobet^1,2, M. Solsona^1,2, M. Mesegue^1,2, S. Gassiot^2,3
Abstract Number: PB1648

Septins Contribute to Platelet Shape and Functionality

O. Kim¹, E. Mordakhanova², O. Vagin³, R. Litvinov^1,2, J. Weisel¹
Abstract Number: PB0237

Sequence Mismatch Between Therapeutic (t) and Endogenous (e) Factor VIII Proteins (FVIIIs), and HLA-class-II (HLAcII)-binding in the Development of Neutralizing Anti-tFVIII-Antibodies in Hemophilia A (HA): Evidence from the PATH Study

V.P. Diego^1,2, M. Almeida^1,2, K.R. Viel³, B.W. Luu^1,2,4, A. Ameri⁵, K. Haack⁶, J. Curran^1,2, J.S. Powell⁷, J. Peralta^1,2, H. Mead⁸, R. Rajalingam⁹, M.A. Escobar¹⁰, L.V. Dinh⁴, S. Williams-Blangero^1,2, C.K. Kasper¹¹, L. Almasy¹², S.A. Cole⁶, J. Blangero^1,2, T.E. Howard^2,4,13
Abstract Number: PB2262

Serial Ultrasounds in Deep Vein Thrombosis Diagnosis, a Single Centre Retrospective Review

R. Yan¹, D. Manos², D. Anderson¹, S. Shivakumar¹
Abstract Number: PB1207

Severe Factor V Deficiency Caused by Two Novel Pathological F5 Variants – First Insights into their Effect on Factor V Function

J. Brodard¹, S. Calzavarini², M. Pavicic³, C. Quarroz⁴, G. Wiedemann⁵, D. Baumgartner¹, N. Porret¹, R. Joncourt¹, O. Kocher¹, K. Jalowiec¹, J. Rössler⁶, A. Angelillo-Scherrer¹, J.A. Kremer Hovinga¹, M. Kartal-Kaess⁷
Abstract Number: PB0505

Severe Haemophilia A Plasma Artificially Spiked with Emicizumab and Recombinant Factor VIII Concentrates: Measurement by One-Stage and Chromogenic Factor VIII Assays

A. Bowyer, S. Kitchen, R. Wardle, R. Maclean
Abstract Number: PB1477

Severe Platelet Dysfunction in Patient with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) after Tyrosine Kinase Inhibitor (TKI) Therapy

M.R. Cozzi¹, M. Battiston², M. Turetta¹, A. Steffan¹, S. Crestani³
Abstract Number: PB1586

Severe Thrombocytopenia after DDAVP Test (DDAVPt) in a Girl with a p.Cys1272Gly Variant of the VWF Gen

J.P. Frontroth, M. Hepner, A. Chaves, C. Pepe, G. Pieroni, E. Annetta, C. Cervio, G. Sciuccati
Abstract Number: OC 07.3

Severity of Acute Events in Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP) with or without Regular Plasma Prophylaxis: Results from the International Hereditary TTP Registry

E. Tarasco^1,2, L. Bütikofer³, G. Sinkovits⁴, Z. Prohászka⁴, A.S. von Krogh⁵, P.N. Knöbl⁶, K.D. Friedman⁷, J.N. George⁸, I. Aebi-Huber^1,2, K.A. Jalowiec¹, Z. Cermakova⁹, M. Górska-Kosicka¹⁰, J. Windyga¹⁰, I. Hrachovinova¹¹, C.R. Largiadèr¹², M. Matsumoto¹³, B. Lämmle^1,14, J.A. Kremer Hovinga^1,2
Abstract Number: PB0140

Sex Bias in Animal Models of Thrombosis Research

P.T. Tieu^1,2, S. Afraz^2,3, N. Dietrich¹, J. Lott¹, C. Slapnicar¹, N. Thai⁴, V. Wang¹, A.K.C. Chan^2,5, D. Matino²
Abstract Number: PB1715

SHARPIN Restrains αIIbβ3 Activation in Platelets in Three Dimensions

A. Kasirer-Friede¹, E. Peuhu^2,3, J. Ivaska^3,4, S. Shattil¹
Abstract Number: PB1611

Short-term Application of Caffeic Acid Specifically Promotes Expansion of Hematopoietic Stem Cells

R. Wang, Y. Liu, X. Liu, Y. Liu, Y. Wang, M. Hou
Abstract Number: PB1153

SIG-001 for Hemophilia A: Preclinical Safety and Efficacy Studies Conducted in Mice and Non-Human Primates

G. Carmona, J. Huang, L. Barney, J. Sewell, K. Lai, C. Carroll, J. Schladenhauffen, M. Kapsimalis, K. Barrett, S. Drapeau, R. Vivaldi, D. Peritt
Abstract Number: PB0588

Sigma Metrics Scores for Routine Haemostasis Assays in a Small Laboratory

H.R.B. Othman
Abstract Number: PB1994

Significance of Macrophage Migration Inhibitory Factor and Toll-Like Receptor 4as Predictive Factors of Sepsis in Shock Patients

S.-H. Choi¹, S.-J. Park¹, K.-W. Kim², Y.-D. Cho¹
Abstract Number: PB1995

Significance of Macrophage Migration Inhibitory Factor for Sepsis in Hemorrhagic Shock Patients

S.-H. Choi¹, K.-W. Kim², S.-J. Park¹, Y.-D. Cho¹
Abstract Number: PB0087

Silent Brain Ischemia in Thalassemia Patients: Breaking the Silence

M. Karimi, S. Haghpanah
Abstract Number: PB0418

Simulation of TF-dependent Factor X Activation on Phospholipid Vesicles: The Role and Importance of Individual Reaction Stages

T. Kovalenko¹, M. Panteleev^1,2, A. Sveshnikova^1,2
Abstract Number: PB0358

Simvastatin Prevents Liver and Kidney Microthrombosis After Exposure to Lipopolysaccharide by Preserving the Antithrombotic Properties of the Endothelium

V. La Mura^1,2,3, N. Gagliano³, F. Arnaboldi³, P. Sartori³, P. Procacci³, E. Liguori³, N. Bitto¹, G. Ristagno⁴, D. Dondossola⁵, F. Salerno³, A. Tripodi⁶, M. Colombo⁷, F. Peyvandi^1,6
Abstract Number: PB1233

Single Center Analysis of the Phenotype of Children Immune Thrombocytopenia with Mutation Related to Common Variable Immunodeficiency

J. Ma, L. Fu, J. Zhang, H. Gu, H. Liu, Z. Chen, R. Wu
Abstract Number: PB2076

Single Centre Daily Practice Evaluation of Bleeding and Thromboembolic Complications in Cancer Patients with Atrial Fibrillation

G. Chu¹, M.V. Huisman¹, H. Gelderblom², M.E. Hemels^3,4, T. van der Hulle², S.A. Trines⁵, F.A. Klok¹
Abstract Number: PB2444

Single Centre Experience of DOAC Use in Patients with Antiphospholipid Syndrome (APS) with Venous Thromboembolism

K.A. Breen, A. Doyle, B.J. Hunt
Abstract Number: PB1184

Single Centre Experience of Rare Bleeding Disorders

M. Martinez, G. Sliba, P. Nally, F. Morales, G. Dolabella, F. Nally
Abstract Number: PB1830

Sirolimus Is Effective in Autoimmune Lymphoproliferative Syndrome (ALPS)/ALPS-Like Syndrome: Results of a Single Centre Experience

H. Gu, Z. Chen, J. Ma, R. Zhang, T. Wang, R. Wu
Abstract Number: PB0488

Six Years of Experience with Plasma Fractionation Industries at a Private Super Speciality Hospital in South India: Renaissance in Usage of Excess Plasma in Blood Banks

B. Bhasker, A. Aluri
Abstract Number: PB0808

Small RNAs Influence the Pathophysiology of Hemophilic Synovitis and Arthropathy

E. Sujanthi^1,2, P. Sarangi¹, S. Amit³, A.S. Ananthan⁴, C. Jamora⁴, P. Vemula⁴, G.R. Jayandharan¹
Abstract Number: PB0121

Small-Molecule Factor XIa Inhibitor, BMS-986177/JNJ-70033093, Prevents and Treats Arterial Thrombosis in Rabbits at Doses that Preserve Hemostasis

P. Wong, E. Crain, A. Dilger, R. Wexler, W. Ewing, D. Gordon, J. Luettgen
Abstract Number: PB0022

Smoking Status as Risk Factor and Risk Factors in Young and Elderly Patients Suffered from Myocardial Infarction

N. Antonijevic¹, D. Matic¹, I. Veljic¹, L. Jovanovic¹, D. Mikovic², A. Beletic³, S. Obradovic⁴
Abstract Number: PB1972

Snake Venom Cysteine-Rich Secretory Proteins (SVCRISPS) from North American Vipers: Mechanism of Action on Blood and Lymphatic Endothelial Cells

M. Suntravat¹, O. Sanchez¹, A. Reyes¹, J. Bernal¹, A. Cantu¹, E. Salazar¹, J. Galan¹, W. Cromer², D. Zawieja², P. Davies³, E. Sanchez¹
Abstract Number: PB1218

Socio-Demographic Data and some Haematological Parameters of Nigerian Children Living on the Street: A Comparative Study

P. Akpan, B. Asuquo
Abstract Number: PB2417

Sodium Valproate-induced Drug Interactions with DOAC Anticoagulant Activity: A Case Report

I. Paskaleva¹, E. Doncheva¹, R. Simeonova², V. Ignatova³, A. Dramov⁴
Abstract Number: PB0430

Soluble Glycoprotein VI is an Independent Predictor of Major Bleeding in Patients with Suspected Heparin-Induced Thrombocytopenia

A. Pishko¹, R. Andrews^2,3, E. Gardiner², D. Lefler¹, A. Cuker^1,4
Abstract Number: PB2017

Specialized Regulatory T Cells Control Venous Blood Clot Resolution

F. Shahneh^1,2, A. Grill¹, M. Klein³, T. Bopp³, K. Schäfer^1,4, V.K. Raker^1,2, C. Becker^1,2
Abstract Number: PB1841

Specific Inhibition of MRP4 Affects Several Signaling Pathways and Thrombus Formation in Human Platelets

R. Wolf¹, S. Grammbauer¹, R. Palankar², E. Moritz¹, A. Greinacher², M. Tzvetkov¹, G. Jedlitschky¹, B.H. Rauch¹
Abstract Number: PB2021

Stabilin-2 Promoter Modulates Immune Response in the Liver of Lentiviral Vector Injected Mice

E. Borroni¹, C. Borsotti¹, V. Bruscaggin¹, M. Talmon¹, R. Famà¹, B.D. Brown², A. Follenzi¹
Abstract Number: PB1353

Stability of Crushed Avatrombopag Tablets Demonstrated in Multiple Food Vehicles

R.F. Grace^1,2, K. Aggarwal³, M. Vredenburg³, J.M. Despotovic^4,5
Abstract Number: PB2039

Standard Versus Higher Intensity Anticoagulation for Patients with Mechanical Aortic Valve Replacement and Additional Risk Factors for Thromboembolism: A Multi-center Registry Analysis

S. Hanigan¹, X. Kong¹, B. Haymart¹, S. Kaatz², G. Krol², V. Shah², J. Kozlowski³, J.B. Froehlich¹, G.D. Barnes¹
Abstract Number: PB0441

Standardization of a Flow Cytometry Platelet Sialylation Assay, and reference Values for Beta-Galactose Exposure in Healthy Subjects

D. Lasne^1,2, T. Pascreau^1,2, S. Darame^1,2, M.-C. Bourrienne¹, P. Tournoux¹, A. Philippe¹, S. Ziachahabi¹, F. Suarez³, A. Marcais³, A. Dupont^4,5, C. Denis², A. Kauskot², D. Borgel^1,2
Abstract Number: PB0363

State of the Hemostatic System in Diffuse Congenital Arteriovenous Malformations of the Extremities

L. Chernukha¹, E. Lugovskoy², O. Kashyrova¹, K. Sergey², T. Platonova²
Abstract Number: PB1505

Strategies for Analysis of Novel Molecular Variants in the RUNX1 Gene as a Cause of Familial Platelet Disorder with Predisposition to Acute Myeloid Leukemia (FPD/AML)

V. Palma-Barqueros¹, J.F. Ruiz-Pividal¹, J.M. Bastida², N. Bohdan¹, M.J. López-Andreo³, R. Teruel Montoya¹, A. Rodriguez-Alen⁴, J. Padilla¹, N. Revilla¹, A. Marin-Quilez², R. Benito², J.R. Gonzalez-Porras², V. Vicente¹, M.L. Lozano¹, J. Rivera¹, On Behalf of the Project “Caracterización Funcional y Molecular de Trastornos Plaquetarios Congénitos”, Grupo de Trabajo de Patología Hemorrágica de la SETH
Abstract Number: PB2077

Stroke, Major Bleeding, and Net-clinical Benefit of Anticoagulation in Patients with Atrial Fibrillation on Hemodialysis

O. Königsbrügge¹, S. Schmaldienst², M. Auinger³, M. Lorenz⁴, R. Klauser-Braun⁵, J. Kletzmayr⁵, I. Pabinger¹, M. Säemann⁶, C. Ay¹
Abstract Number: PB1523

Structural Analysis of the VWF molecule with Compound in Cis Heterozygous p.R924Q and p.A2178S Mutations Causing a Type 2B-Like von Willebrand Disease

M. Sacco¹, M. Ferrarese², S. Lancellotti³, M. Tardugno¹, M. Basso³, M. Papi⁴, F. Bernardi², G. Castaman⁵, R. De Cristofaro¹
Abstract Number: PB2197

Structural Basis of the Pro-coagulant Phenotype of Prothrombin Variant Arg553Trp (p.Arg596Trp – Padua 2)

L. Acquasaliente¹, A. Covallero¹, D. Peterle², C. Bulato², P. Simioni², V. De Filippis¹
Abstract Number: PB0253

Structure-Function Relationships in Factor XII Studied with Factor XII-HGFA Chimeras

A. Shamanaev, I. Ivanov, M.-F. Sun, D. Gailani
Abstract Number: PB0183

Structures in the Presence and Absence of an Anti-Factor VIII C1 Domain Antibody Bound to a Bioengineered Factor VIII Construct Indicates Multiple C2 Domain Conformations

J. Gish¹, L. Jarvis¹, S. Peters¹, K. Childers¹, I. Smith¹, E. Parker², J. Healey², H.T. Spencer², C. Doering², P. Lollar², P.C. Spiegel¹
Abstract Number: PB0412

Study of a New Synthetic Thrombin Inhibitor IEM-2280

D. Grigorieva¹, A. Sokolov^2,3, E. Litasova², E. Shamova¹, I. Gorudko¹
Abstract Number: PB0057

Study of Fluctuations in the Endothelin Concentration of the Crew Trans-Latitude Journey Transarctica-2019

N. Vorobyeva¹, E. Melnichuk², E. Beliakov²
Abstract Number: PB2209

Study of Plasma miRNAs and Microparticle miRNAs in Severe Forms of Pulmonary Hypertension

J. Oto¹, O. Tura-Ceide², V. Sánchez-López³, J. Osorio², C. Bonjoch², D. Hervás⁴, E. Arellano⁵, P. Medina¹, I. Blanco², V.I. Peinado², R. Otero⁶, J.A. Barberà², * J Oto and O Tura-Ceide have contributed equally to this work.
Abstract Number: PB2078

Study of Real Clinical Practice to Evaluate the Efficacy and Safety of Edoxaban in Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation. Differences between Results by Age and Creatinine Clearance Greater than 95 ml/min

A. Garcia Ruiz¹, P. Romero Garcia², E. Morente Constantin¹, M. Jurado Chacón¹
Abstract Number: PB0069

Study of the Endothelial Dysfuncion in Patients with Cancer: Preliminary Results

E. Borella, E. Campello, L. Spiezia, F. Dalla Valle, A. Poretto, G. Turatti, M. Marobin, C. Simion, P. Simioni
Abstract Number: PB0484

Study of the Stability of the Main Parameters of Hemostasis Over Six Hours

S. Hadjali-Saichi, K. Guenounou-Guemmour, I. Frigaa
Abstract Number: PB2504

Study of the State of the Hemostatic System in Women with Various Pregnancy Complications

I. Gribkova¹, N. Koroleva², A. Murashko²
Abstract Number: PB0058

Study of Thrombine Generation Assay Parameters of the Crew Trans-Latitude Journey Transartika-2019

N. Vorobyeva¹, E. Melnichuk², E. Beliakov²
Abstract Number: PB1014

Subclinical deep venous thrombosis identified in 7,5% of people with hemophilia undergoing major orthopedic surgery in the absence of pharmacological thromboprophylaxis

G. Verstraete¹, C. Lambert¹, F. Hammer², C. Hermans¹
Abstract Number: PB1227

Successful Development and Implementation of Pharmacist-led VTE Stewardship. An Australian Tertiary Hospital Perspective

J. Chong^1,2, C. Curtain², F. Gad³, F. Passam⁴, G. Soo¹, R. Levy³, R. Burke⁵, S. Dunkley⁴, N. Wong-Doo⁶, V. Chen⁶
Abstract Number: PB1791

Successful Improvement Sexual Dysfunction After Pelvic Irradiation by Platelet Growth Factor

S. Mohammadi^1,2, A. Samaie Nouroozi³, O. Seidi Zadeh⁴, M. Nikbakht^1,2, M. Bagherian², S.A. Musavi^1,2
Abstract Number: PB1077

Successful Inhibitor Eradication for Hemophilia A Children with Poor-risk High-titer Inhibitor Using Low-dose Immune Tolerance Induction Strategy

Z. Li¹, Z. Chen¹, X. Cheng¹, X. Wu¹, G. Li¹, Y. Zhen¹, S. Cai², M.-C. Poon³, R. Wu¹
Abstract Number: PB0881

Successful Multiple Surgeries in Adult Patients with Haemophilia A (HA) Treated With Turoctocog Alfa Pegol (N8-GP) in the Pathfinder 3 trial

K. Hampton¹, W.H.O. Clausen², S. Benchikh El Fegoun³, A. Landorph²
Abstract Number: PB0984

Successful Parotid Tumor Surgery in Hemophilia a Patient after Immune Tolerance Induction (ITI) with High-Purity Human FVIII/ von Willebrand Factor (vWF)

M. Savitri, P.Z. Ramadhan, P.N. Amrita, M.N. Diansyah, U.Y. Bintoro, A. Ashariati
Abstract Number: PB1484

Successful Perioperative Hemostasis for Glyoblastoma Surgery in a Patient with Glanzmann Thrombasthenia

D. Schiavo^1,2, R. Campanella³, V. Conte⁴, M. Capecchi¹, A. Artoni¹, F. Peyvandi^1,5
Abstract Number: PB2565

Successful Pregnancy Outcomes in Patients with Protein S Deficiency Treated with Daily Fondaparinux Regimen

A. Permatasari¹, M. Savitri², P.Z. Ramadhan², U.Y. Bintoro², A. Ashariati²
Abstract Number: PB1573

Successful Surgical Interventions In Children with von Willebrand Disease Type 3

K. Papayan, N. Savenkova, E. Felker, A. Veselov, A. Gurina, E. Snezhkova, A. Bykov, A. Nesterchuk, N. Nemstsveridze, V. Avramenko, S. Yakunin
Abstract Number: PB0794

Successful Treatment of a Rare Acquired Thrombin Inhibitor in a Patient with Hemodialysis-dependent End-stage Renal Disease

C. Moonla^1,2, B. Akkawat^1,2, A. Sukperm^1,2, M. Meesanun^1,2, R. Jantasing^1,2, P. Lawasut^1,2, K. Takkavatakarn¹, P. Cheanklin^1,2, S. Krajibthong^1,2, P. Watanaboonyongcharoen^2,3, N. Uaprasert^1,2, P. Rojnuckarin^1,2
Abstract Number: PB1060

Successful Use of Immunotherapy in the Management of Cancer in Patients with Hemophilia B

D. Hedrick
Abstract Number: PB0186

Suppression of Factor VIII-Specific Memory B Cells by Murine and Human BAR-Tregs

D. Scott¹, A. De Paula Pohl¹, S. Venkatesha², A. Zhang¹
Abstract Number: PB1085

Surgery in People with Hemophilia and Inhibitors: 10 Years of Experience in a Portuguese Comprehensive Care Centre

C. Vaz, F. Vasconcelos, S. Fernandes, M. Reis, M. Carvalho, M. Koch
Abstract Number: PB0939

Surgical Experience from the Phase III STASEY Trial of Emicizumab Prophylaxis in Persons with Hemophilia A (PwHA) with FVIII Inhibitors: Data from the Second Interim Analysis

G. Castaman¹, E. Santagostino², J. Kremer Hovinga³, R. Schutgens⁴, S. Robson⁵, O. Meier⁵, V. Jiménez-Yuste⁶
Abstract Number: PB1154

Surgical Experience with Emicizumab: A Single Centre Experience with Central Venous Access Device Removal

S. Badle, D. Gosrani, A. Taylor, K. Sibson, M. Mathias, R. Liesner
Abstract Number: PB1096

Surgical Experience with Fidanacogene Elaparvovec

L.A. George¹, S.K. Sullivan², K.A. High³, J.E. Murphy⁴, L. Smith⁵, J. Rupon⁵
Abstract Number: PB1104

Surgical Management of a Hemophilia B Gene Transfer Clinical Trial Participant: A Case Report Following Etranacogene Dezaparvovec (AMT-061) Gene Therapy

A. Giermasz¹, D. Lickorish², E. Sawyer³, R. Gut³, E. Gomez⁴
Abstract Number: PB0986

Surrogate FVIII Activity in Patient and Constructed Plasma Samples Containing Emicizumab: A National External Quality Assurance Scheme for Blood Coagulation (UK NEQAS BC) Exercise

A. Lowe, I. Jennings, S. Kitchen, D. Kitchen, L. Brown, S. Munroe-Peart, I. Walker
Abstract Number: PB2440

Survey on the Prescription and Biological Monitoring of Direct Oral Anticoagulants in Algeria

S. Bounaas
Abstract Number: PB2103

Survival after Cancer-related Venous Thrombosis: The Scandinavian Thrombosis and Cancer Study (STAC)

M.J.T. Crobach^1,2, R.J.S. Anijs^1,3, S.K. Brækken^4,5, M.T. Severinsen⁶, J. Hammerstrøm⁷, H. Skille^4,5, S.R. Kristensen⁶, B. Paulsen^4,5, A. Tjønneland⁸, H.H. Versteeg¹, K. Overvad^9,10, J.-B. Hansen^4,5, I.A. Næss¹¹, S.C. Cannegieter^1,3
Abstract Number: PB1343

Sustained Remission after Withdrawal of Thrombopoietin Receptor-Agonists in Immune Thrombocytopenia

J. Yamanouchi, T. Hato, Y. Ikeda, K. Takenaka
Abstract Number: PB1073

Switch to Extended Half-life Recombinant Single Chain Factor VIII in Haemophilia A Patients. Experience in One Centre

R. Jimenez-Barcenas, R.J. Nuñez-Vazquez, B. Pedrote-Amador, F.J. Rodriguez-Martorell, J.A. Perez-Simon
Abstract Number: PB1542

Symptomatic Venous Aneurysm of the Internal Jugular Vein Presenting with Small Thrombotic Inclusions in von Willebrand Disease Type I

K. Guetl¹, C. Reiter², R.H. Portugaller³, K. Tiesenhausen⁴, P. Gressenberger¹, V. Muster¹, M. Brodmann¹, T. Gary¹
Abstract Number: PB1388

Synthesis of Antiplatelet Ortho-Carbonyl Hydroquinones: A Spiro Derivative is Selective against Collagen-Stimulated Platelets

E. Fuentes¹, D. Mendez¹, F. Urra², J.P. Millas-Vargas¹, M. Alarcón¹, I. Palomo¹, R. Araya-Maturana¹
Abstract Number: PB0024

Synthetic Antisense Oligodeoxynucleotides – Loaded Microbubbles – Mediated Transfection Therapy using B-Mode Ultrasound – Guided Focused Shock Waves Decreases Neointimal Hyperplasia Restenosis after Laser Angioplasty of Advanced Atherosclerotic Severe Stenosis

H. Mehrad¹, A. Foletti²
Abstract Number: PB0409

System Wide Investigation into Coagulation Profile of Premature Myocardial Infarction Subjects

J. Dunster¹, J. Wright^2,3, A. Goodall^2,3
Abstract Number: PB2471

Systematic Review of the Risk of Bleeding in Patients with Chronic Kidney Disease Treated with Tinzaparin

E. Colomé, M. Merino, Y. de Miguel
Abstract Number: PB2510

Systematic Review of Viscoelastic Testing (TEG/ROTEM) in Obstetrics and Recommendations for Future Studies

A. Amgalan¹, T. Allen², M. Othman^3,4, H. Ahmadzia⁵
Abstract Number: PB0075

Systemic Aspirin Esterification in Subjects with Cardiovascular Disease: Impact of Body Size

B. Porro¹, A. Di Minno², F. Veglia¹, M. Giroli¹, J.P. Werba¹, S. Barbieri¹, S. Eligini¹, S. Fiorelli¹, B. Rocca³, V. Cavalca¹, E. Tremoli¹
Abstract Number: PB2519

Systemic Evaluation of Neuroserpin, Interleukin-17 and Hemostatic Factors in Association with Clinical Parameters in Preeclamptic Women: A Principal Component Analysis Approach

L. Oliveira Perucci¹, S. Pio Gomes da Silva¹, L.Â. Gonçalves de Moraes¹, P. Nessralla Alpoim², L. Carvalho Godoi², L.M. Sant'Ana Dusse², A. Talvani¹
Abstract Number: PB1999

Systemic Inflammation in Sepsis Patients Is Demonstrated by Levels of IL-8, IL-13, and TAFI

E. Bontekoe¹, D. Joshi¹, M. Rondina², E. Middleton², A. Blair², F. Siddiqui¹, D. Hoppensteadt¹, J. Fareed¹
Abstract Number: PB1598

Systmetic Study of Biological Properties and Functions of Bone Marrow Mesenchymal Stem Cells from Patients with Essential Thrombocythemia and Explore the Effects of Interferonα-2b on Them

T. Sun, A. Zhang